| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 08/23/2000 | CN1055679C Phenethylamine derivative with cardiovascular activity |
| 08/22/2000 | US6107337 Antiarthritic agents; anticarcinogenic agents |
| 08/22/2000 | CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 08/17/2000 | WO2000047566A1 Phenylsulfonyl ureas, methods for producing them and their use as herbicides and plant growth regulators |
| 08/17/2000 | WO2000047554A2 INHIBITORS OF FACTOR Xa |
| 08/17/2000 | WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
| 08/17/2000 | WO2000047552A1 Tyrosine alkoxyguanidines as integrin inhibitors |
| 08/17/2000 | WO2000047551A2 Inhibitors of aspartyl protease |
| 08/17/2000 | CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa |
| 08/17/2000 | CA2362372A1 Tyrosine alkoxyguanidines as integrin inhibitors |
| 08/17/2000 | CA2361428A1 Inhibitors of factor xa |
| 08/16/2000 | EP1027329A1 Dofetilide polymorphs |
| 08/16/2000 | EP1027328A1 Substituted anilides |
| 08/16/2000 | EP0863869B1 Method of preparing 2-trifluoromethoxybenzene sulphonamide |
| 08/16/2000 | CN1055474C Noval crystal type anhydrous 7-([1 alpha, 5 alpha, 6 alpha]=6-amino-3-azabicyclo [3,1,0] hexyl-3-group)-6-fluorine-1-(2,4-difluorophenyl |
| 08/15/2000 | US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent |
| 08/15/2000 | US6103766 Substituted or unsubstituted phenylsulfonamide-phenylamine derivatives useful for treating the disorders related to central nervous system |
| 08/15/2000 | US6103761 Agents acting at cholecystokinin receptors |
| 08/15/2000 | US6103720 Ketobenzamides as calpain inhibitors |
| 08/15/2000 | US6103711 Inhibitors of interleukin-1β converting enzyme |
| 08/10/2000 | WO2000046189A1 Sulfonamide derivatives having cyclic structures |
| 08/10/2000 | WO2000046187A2 Antizyme modulators and their use |
| 08/10/2000 | WO2000045807A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
| 08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
| 08/10/2000 | CA2362259A1 Antizyme modulators and their use |
| 08/09/2000 | EP1025840A2 Oral drug compositions and methods |
| 08/09/2000 | CN1262624A Use of colchinol derivatives as vascular damaging agents |
| 08/08/2000 | US6100428 Reacting optionally protected thioureas and isothioureas with amines in the presence of a nickel catalyst to form a compound comprising a guanidine; high yields, mild reaction conditions |
| 08/08/2000 | US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/03/2000 | WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 08/03/2000 | WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 08/03/2000 | WO2000006610A3 Polymer production |
| 08/03/2000 | WO2000006146A9 Substituted anilide compounds and methods |
| 08/03/2000 | WO2000003975A3 Aryl vinyl ether derivatives and their use as herbicides |
| 08/03/2000 | DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis |
| 08/03/2000 | CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 08/02/2000 | EP1024134A1 Aminobutanoic acid derivatives |
| 08/02/2000 | EP1024130A1 Biphenyl-5-alkanoic acid derivatives and use thereof |
| 08/02/2000 | EP1023356A1 Specific fluorinated ethers as reaction medium |
| 08/02/2000 | EP1023295A1 Fibrinogen receptor antagonist prodrugs |
| 08/02/2000 | CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 08/02/2000 | CN1261688A 照相黄色成色剂 Photographic yellow couplers |
| 08/01/2000 | US6096924 In the presence of at least one vanadium compound of oxidation state 0, ii, iii, iv, or v, wherein said vanadium compound is dissolved or dispersed in said solution or melt. |
| 08/01/2000 | US6096768 Administering a 3, 5, 6-substituted phenyl compound for the treatment of inflammation and autoimmune disorders |
| 08/01/2000 | CA2140887C New nimesulide salt cyclodextrine inclusion complexes |
| 08/01/2000 | CA2019335C Phenylalkan (en)oic acids |
| 07/27/2000 | WO2000043356A1 Novel cationic couplers and their use for oxidation dyeing |
| 07/27/2000 | WO2000042971A2 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999057098A3 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 07/27/2000 | CA2323708A1 Novel cationic couplers and their use for oxidation dyeing |
| 07/27/2000 | CA2323698A1 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021398A1 Pesticidal compositions |
| 07/26/2000 | EP1021397A1 Benzanthrone compounds and antiviral uses thereof |
| 07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 07/26/2000 | CN1261356A Substituted aminobeterocyclylamides |
| 07/25/2000 | US6093848 Preparation of substituted guanidine derivatives |
| 07/25/2000 | US6093744 N-acyl sulfamic acid esters useful as hypocholesterolemic agents |
| 07/25/2000 | US6093742 Inhibitors of p38 |
| 07/25/2000 | CA2272597A1 Quaternary ammonium salts of sulfonylurea |
| 07/20/2000 | WO2000042012A1 φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS |
| 07/20/2000 | WO2000042004A1 Benzenic sulphonamide derivatives and their uses |
| 07/20/2000 | WO2000042003A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | WO2000042002A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | WO2000041997A1 Process for the preparation of optically active amino alcohols |
| 07/20/2000 | WO2000041994A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/20/2000 | WO2000041531A2 Serine protease inhibitors |
| 07/20/2000 | WO2000041469A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS |
| 07/20/2000 | DE19901061A1 Treatment of dysfunction of autonomous nervous system, especially vagal system of the heart, with benzenesulfonyl(thio)urea derivatives optionally with beta-receptor blocker |
| 07/20/2000 | CA2360356A1 .beta.-phenylalanine derivatives as integrin antagonists |
| 07/20/2000 | CA2356934A1 Serine protease inhibitors |
| 07/20/2000 | CA2356290A1 Benzenic sulphonamide derivatives and their uses |
| 07/20/2000 | CA2349832A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | CA2349467A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | CA2348236A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/19/2000 | EP1020438A2 Ionic fluorinated sulphonamides and sulphones |
| 07/19/2000 | EP1020437A1 Process for producing halogenoalkylsulfonamide derivatives |
| 07/19/2000 | EP1020434A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
| 07/19/2000 | EP1019368A1 Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same |
| 07/19/2000 | EP1019364A2 Inhibitors of protein tyrosine phosphatase |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019035A1 Il-8 receptor antagonists |
| 07/19/2000 | EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 07/19/2000 | EP0815067B1 Process for the alkoxylation of fluorinated alcohols |
| 07/19/2000 | CN1260345A Hydrazide compound, its preparing method and medicine compositions thereof |
| 07/19/2000 | CN1054598C Pharmacalogically active hydrazine derivatives and process for preparation thereof |
| 07/18/2000 | US6090981 Antiarrhythmics. |
| 07/18/2000 | US6090852 Matrix metalloprotease inhibitor |
| 07/18/2000 | US6090250 Chiral surfactants and methods for their use in chiral separations |
| 07/13/2000 | WO2000040571A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
| 07/13/2000 | WO2000040560A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 07/13/2000 | WO2000040558A1 Aspartic protease inhibitors |
| 07/13/2000 | WO2000015204A3 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers |
| 07/13/2000 | WO2000006083A3 Sulfonamide derivatives |
| 07/13/2000 | CA2358578A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |